Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression

ClinicalTrials.gov ID: NCT01432236

Public ClinicalTrials.gov record NCT01432236. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 3:47 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3b Multicenter, Double-blind, Randomized, Placebo-controlled, 2-way Crossover Study Of Pregabalin In The Treatment Of Fibromyalgia With Concurrent Antidepressant Therapy For Comorbid Depression (Protocol A0081275)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The intent of this study is to identify and treat fibromyalgia subjects with comorbid depression who are receiving an SSRI (selective serotonin reuptake inhibitor) or SNRI (selective norepinephrine reuptake inhibitor) primarily for their depression and to determine whether pregabalin demonstrates improvement relative to placebo in improving pain associated with fibromyalgia.

Study identification

NCT ID
NCT01432236
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
197 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2011 (Type not available)
Primary completion
Jul 2013 (Actual)
Completion
Jul 2013 (Actual)
Last update posted
Jan 22, 2021

2011 – 2013

United States locations

U.S. sites
26
U.S. states
18
U.S. cities
24
Facility City State ZIP Site status
Genova Clinical Research Tucson Arizona 85704 —
SDS Clinical Trials Orange California 92868 —
Research Across America Santa Ana California 92705 —
Innovative Research of West Florida, Inc. Clearwater Florida 33756 —
Florida Medical Center & Research, Inc. Coral Gables Florida 33134 —
Meridien Research Tampa Florida 33606 —
Medical Research and Health Education Foundation, Inc. Columbus Georgia 31909 —
Heartland Research Associates, LLC Wichita Kansas 67207 —
Central Kentucky Research Associates, Inc. Lexington Kentucky 40509 —
Boston Clinical Trials Boston Massachusetts 02131 —
Michigan Head Pain and Neurological Institute Ann Arbor Michigan 48104 —
Quality Clinical Research, Inc. Omaha Nebraska 68114 —
Social Psychiatry Research Institute Brooklyn New York 11235 —
University of Cincinnati Cincinnati Ohio 45219 —
Radiant Research, Inc. Columbus Ohio 43212 —
Midwest Clinical Research Center Dayton Ohio 45417 —
Sunstone Medical Research, LLC Medford Oregon 97504 —
Behavioral Medicine Center Wyomissing Pennsylvania 19610 —
Clinical Research Center of Reading, LLP Wyomissing Pennsylvania 19610 —
Coastal Medical East Greenwich Rhode Island 02818 —
Omega Medical Research Warwick Rhode Island 02886 —
Coastal Carolina Research Center Mt. Pleasant South Carolina 29464 —
FutureSearch Trials of Neurology Austin Texas 78731 —
Fatigue Consultation Clinic Salt Lake City Utah 84102 —
Lifetree Clinical Research, LC Salt Lake City Utah 84106 —
Charlottesville Medical Research Charlottesville Virginia 22911 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01432236, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 22, 2021 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01432236 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →